Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Marilena Bertini"'
Autor:
Sabina Tangerini, Lisa Di Mascolo, Franco Locatelli, Laura Palmucci, Alessia Montanari, Marilena Bertini, Mattia Viano, Chiara Schiavo
Publikováno v:
J. of Health Science. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0939812cc1a62e06a78c5851783030c2
https://doi.org/10.17265/2328-7136/2018.05.002
https://doi.org/10.17265/2328-7136/2018.05.002
Autor:
Arturo Rosso, Luigi Pegoraro, Bruna Giovinazzo, Marilena Bertini, Gian Carlo Avanzi, Luigi Resegotti, Lorella Depaoli
Publikováno v:
European Journal of Haematology. 43:173-177
Here we report 3 cases of trisomy 11 observed in 1 patient with secondary acute myeloblastic leukaemia and in 2 patients with spontaneous acute myeloblastic leukaemia. In all 3 patients, the picture of overt acute leukaemia arose following a clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e849355c06f4698b32ec1549e945022d
https://doi.org/10.1111/j.1600-0609.1989.tb00274.x
https://doi.org/10.1111/j.1600-0609.1989.tb00274.x
Autor:
Enrico Roggero, Felice Pasini, Marilena Bertini, Elena Oldani, Achille Ambrosetti, Umberto Vitolo, Tiziano Barbui, Carlo Tondini, Franco Cavalli, Graziella Pinotti, Sergio Cortelazzo, M. Busetto, Andrea Rossi, Emanuele Zucca, Lorenzo Gianni
Publikováno v:
Annals of Oncology. 10:1433-1440
sOncologia,Ospedale 'Infermi', Rimini, Italy Summary Background: The definition of prognostic parameters in early stages of gastric lymphoma is still controversial. The aim of this retrospective analysis was to assess the value of the stagemodified i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4c5fae464feb877804506a6805a34fc
https://doi.org/10.1023/a:1008351427601
https://doi.org/10.1023/a:1008351427601
Autor:
A. Carbone, Cosimo Sacco, Ernesta Audisio, Vittorina Zagonel, Daniela Capello, Domenico Novero, Lorella Orsucci, Umberto Mazza, Gianluca Gaidano, Marilena Bertini, Giorgio Palestro, R Calvi, Gisella Volpe, Luigi Resegotti, Barbara Botto, Giuseppe Saglio, Roberto Freilone, Umberto Vitolo, Cristina Pastore, Guido Parvis
Publikováno v:
Annals of Oncology. 9:55-61
Summary Background B-diffuse large-cell lymphomas (DLCL) have been associated with some molecular lesions, but the role of such lesions as prognostic markers is still controversial. This report concerns an investigation of the frequency and clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49835797e61c8fcb515f15c909b73256
https://doi.org/10.1023/a:1008201729596
https://doi.org/10.1023/a:1008201729596
Autor:
R Calvi, Lorella Orsucci, Andrea Gallamini, D. Rota Scalabrini, L. Griso, A. Levis, Barbara Botto, Riccardo Ghio, M. Cucchi, Umberto Ricardi, V. Secondo, Umberto Vitolo, Roberto Freilone, Ernesta Audisio, A. De Crescenzo, Marilena Bertini, G. Massara, Luigi Resegotti, Flavia Salvi
Publikováno v:
Scopus-Elsevier
Summary Background: >A cooperative study was undertaken to evaluate the efficacy and toxicity of a very brief course of chemotherapy followed by locoregional radiotherapy in patients with localized-stage intermediate- to high-grade non-Hodgkin's lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5afe46950ae2fe1b51e55c94e6008a
https://doi.org/10.1093/oxfordjournals.annonc.a010794
https://doi.org/10.1093/oxfordjournals.annonc.a010794
Autor:
Umberto Mazza, Barbara Botto, Cristina Pastore, Ernesta Audisio, A. Carbone, Marilena Bertini, Domenico Novero, Luigi Resegotti, Gianluca Gaidano, Paolo De Giuli, Giuseppe Saglio, Susanna Cappia, Giorgio Palestro, Gisella Volpe, Umberto Vitolo, Roberto Freilone
Publikováno v:
Università degli Studi del Piemonte Orientale-IRIS
B-lineage diffuse large cell lymphoma (B-DLCL) arising de novo is characterized by a marked degree of clinical heterogeneity. To determine whether or not the clinical heterogeneity of de novo B-DLCL is reflected by heterogeneity in the molecular feat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e82649dce89f4b98481dfee2c37a3c2
https://doi.org/10.1002/(sici)1098-2264(199605)16:1<21::aid-gcc3>3.0.co
https://doi.org/10.1002/(sici)1098-2264(199605)16:1<21::aid-gcc3>3.0.co
Autor:
Anna Novarino, V. Meneghini, Urgesi A, Domenico Novero, A. Levis, Umberto Vitolo, Corrado Tarella, G. Luxi, Lorella Orsucci, Marilena Bertini, Eugenio Gallo, Luigi Resegotti, Giuseppe Todeschini, Michele Pizzuti
Publikováno v:
Annals of Oncology. 2:733-737
Summary In a series of 193 patients with advanced stage diffuse large-cell lymphoma (DLCL) treated with MACOP-B, 18 (11%) were defined as having a stage II large B-cell lymphoma with sclerosis of the mediastinum. This type of lymphoma has been report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6daed3b9bbac163fd12cf97fdd1b0956
https://doi.org/10.1093/oxfordjournals.annonc.a057853
https://doi.org/10.1093/oxfordjournals.annonc.a057853
Autor:
Valentina Giai, Mariella Genuardi, Marilena Bertini, Chiara Dellacasa, Mario Boccadoro, Roberto Sorasio, Antonella Darbesio, Dario Ferrero
Publikováno v:
British journal of haematology. 144(3)
The efficacy of human recombinant erythropoietin (rEPO) in myelodysplastic syndromes (MDS) has generally been best in untransfused patients with 'refractory anaemia' according to the World Health Organization (WHO). We treated 63 MDS patients [exclud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7961c95c9f4c3f06969a282f10ccc7
https://pubmed.ncbi.nlm.nih.gov/19036104
https://pubmed.ncbi.nlm.nih.gov/19036104
Autor:
E. Naglieri, Luigi Marcheselli, F. Di Vito, Eugenio Gallo, Anna Marina Liberati, Elsa Pennese, Marilena Bertini, Francesco Merli, Stefano Luminari, Massimo Federico, Giuseppe Polimeno, L. Orsucci, Luca Baldini, Barbara Botto, Giuseppina Cabras, Umberto Vitolo, Mozzana R
Publikováno v:
Leukemialymphoma. 48(2)
The Intergruppo Italiano Linfomi started, in 1996, a randomized trial for the initial treatment of elderly patients (older than 65 years) with Diffuse Large B-Cell Lymphoma (B-DLCL) comparing 6 courses of Mini-CEOP vs 8 weeks of P-VEBEC chemotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e6cf8ae477629b33d494c084999c29a
https://pubmed.ncbi.nlm.nih.gov/17325880
https://pubmed.ncbi.nlm.nih.gov/17325880
Autor:
Lucia Miligi, Paolo Vineis, Adele Seniori Costantini, Emanuela Barletta, Franco Leoni, Giuseppe Gorini, Stefania Ciolli, Laura Davico, Gabriele Mugnai, Marilena Bertini, Giuseppe Matullo
Mutations of the N- and K-ras genes occur in approximately 15-30% of acute myeloid leukaemia patients. The role of the oncogenic ras in leukaemogenesis remains unclear. Few studies have revealed that mutations in the ras oncogene family are more prob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f7568315751084a1afd80a5a0288928
http://hdl.handle.net/2318/36803
http://hdl.handle.net/2318/36803
